REVOLUTION Medicines Funding & Investors
Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.
revolutionmedicines.comTotal Amount Raised: $1,075,000,064
REVOLUTION Medicines Funding Rounds
Post Ipo Equity
$264,500,000
Post Ipo Equity
$260,900,000
Series C
$100,000,000
Series C Investors
Cormorant CapitalSchroder AdveqVivo CapitalThird Rock VenturesNextech InvestBiotechnology Value FundThe Column GroupFidelity Management and Research CompanyBoxer CapitalDeerfield Capital ManagementCasdin CapitalSeries B
$56,000,000
Series B Investors
Schroder AdveqNextech InvestThird Rock VenturesThe Column GroupCasdin CapitalSeries A
$25,000,000
Series A Investors
Third Rock VenturesThe Column GroupPost Ipo Equity
$323,600,000
Series A
$45,000,000
Series A Investors
Third Rock Ventures
Funding info provided by Diffbot.